We’re In The News

As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.

Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.

FDA Approved — And Ineffective

June 5, 2025: New report in The Lever shows that most drugs approved by the FDA do not meet the standards of evidence required by law and we say that the FDA’s standards are the lowest ever

Right Diagnosis, Wrong Prescription: Experts Weigh In on RFK, Jr’s Food Safety and Nutrition Policies

Medscape, June 4, 2025: NCHR and other experts agree that RFK Jr plans to improve food safety deserve attention, but debate whether these plans benefit nutrition or will be defeated by anti-regulatory pressure from the White House and Republicans in Congress.

Trump’s diversity purge freezes hundreds of millions in medical research at universities across the country

CNN reports how cuts in university research projects harm important efforts to improve health and save lives in red and blue states. NCHR says researchers are scared about the future of their work and explains how important it is to study differences in how patients develop diseases and which treatments are most effective. We suggest that studies using terms like diversity could be funded if described accurately but with different wording.

Susan Franklin Wood Obituary

The Lancet, April 19, 2025: We share this obituary in The Lancet medical journal of our friend and former board member, Susan Wood. Susan was loved and admired by many. Her impressive work to improve women’s health and the safety of medical products reflected her personal experience and leaves a legacy of inspiring public health advocacy.

In Vague Announcement, FDA Says It Will Cut Ad Comm Conflicts

IHP News, April 17, 2025: Inside Health Policy reports FDA‘s new conflict of interest policy looks like its old conflict of interest policy. NCHR’s Diana Zuckerman and Public Citizen’s Michael Abrams ask how is this new policy different from the existing policy? Industry representatives are already not allowed to vote on FDA advisory committees.